Mosunetuzumab Monotherapy is an effective and well-tolerated Treatment Option in Patients with relapsed/refractory follicular Lymphoma who have previously received plus or minus 2 Lines of Therapy: Key Results from a Phase I/II Study

G. Hess,L. E. Budde, L. H. Sehn,M. Matasar, S. J. Schuster,S. Assouline,P. Giri, J. Kuruvilla,M. Canales,S. Dietrich,K. Fay,M. Ku,L. Nastoupil,M. C. Wei, S. Yin, M. Y. Doral,C. -C. Li,H. Huang,R. Negricea,E. Penuel, C. O'Hear,N. L. Bartlett

ONCOLOGY RESEARCH AND TREATMENT(2022)

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined